Literature DB >> 27193215

Scleroderma-like skin changes occurring after the use of paclitaxel without any chemical solvents: a first case report.

Kana Shibao1, Naoko Okiyama1, Hiroshi Maruyama1, Furuta Jun-Ichi1, Manabu Fujimoto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27193215     DOI： 10.1684/ejd.2016.2763

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  4 in total

1.  Nanoparticle Albumin-Bound Paclitaxel- and/or Gemcitabine-Induced Scleroderma Accompanied by Acanthosis Nigricans-Like Skin Changes.

Authors:  Sei-Ichiro Motegi; Mai Ishikawa; Akiko Sekiguchi; Osamu Ishikawa
Journal:  Case Rep Dermatol       Date:  2019-10-02

Review 2.  Cytoskeleton Reorganization in EndMT-The Role in Cancer and Fibrotic Diseases.

Authors:  Wojciech Michał Ciszewski; Marta Ewelina Wawro; Izabela Sacewicz-Hofman; Katarzyna Sobierajska
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 3.  Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma.

Authors:  Thanika Ketpueak; Wanitcha Chanloung; Kittiya Na Nan; Chontara Pongsananurak; Nuntana Kasitanon; Worawit Louthrenoo
Journal:  Clin Rheumatol       Date:  2022-09-09       Impact factor: 3.650

4.  Association between CA 15‑3 and progression of interstitial lung disease in a case of coexisting systemic sclerosis and recurrent breast cancer: A case report.

Authors:  Masahiro Ohara; Yumiko Koi; Tatsunari Sasada; Keiko Kajitani; Seishi Mizuno; Ai Takata; Atsuko Okamoto; Ikuko Nagata; Mie Sumita; Kaita Imachi; Mayumi Watanabe; Yutaka Daimaru; Yusuke Yoshida
Journal:  Mol Clin Oncol       Date:  2022-08-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.